Related Experiment Videos

Pharmacology of nonpeptide angiotensin II receptor antagonists

R D Smith¹, A T Chiu, P C Wong

¹Cardiovascular Diseases Research, Du Pont Merck Pharmaceutical Company, Wilmington, Delaware 19880-0400.

Annual Review of Pharmacology and Toxicology

|January 1, 1992

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Pharmacological properties of angiotensin II receptor antagonists.

The Canadian journal of cardiology·1999

Combined spinal-epidural analgesia in the management of labouring parturients with mitral stenosis.

Anaesthesia and intensive care·1999

Angiotensin II receptor antagonists: an emerging new class of cardiovascular therapeutics.

Hypertension research : official journal of the Japanese Society of Hypertension·1999

Selective, covalent modification of beta-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors.

Proceedings of the National Academy of Sciences of the United States of America·1999

Rationale, background, and design of the randomized angiotensin receptor antagonist--angiotensin-converting enzyme inhibitor study (RAAS).

The American journal of cardiology·1996

Historical development of losartan (DuP 753) and angiotensin II receptor subtypes.

Blood pressure. Supplement·1996

See all related articles